Haemophilus B and hepatitis B vaccine
- J07CA08 (WHO)
- 820977-94-4
- none
Haemophilus B and hepatitis B vaccine is a combination vaccine whose generic name is Haemophilus b conjugate and hepatitis B recombinant vaccine.[1][2] It protects against the infectious diseases Haemophilus influenzae type B and hepatitis B.[2]
A branded formulation, Comvax, was marketed in the US by Merck.[3][4] It was discontinued in 2014.[5]
References
- ^ "Comvax". Drugs.com. Retrieved 15 July 2018.
- ^ a b "Haemophilus b conjugate and hepatitis b vaccine Intramuscular Advanced Patient Information". Drugs.com. 14 February 2020. Retrieved 13 September 2020.
- ^ Centers for Disease Control and Prevention (February 1997). "FDA approval for infants of a Haemophilus influenzae type b conjugate and hepatitis B (recombinant) combined vaccine" (PDF). MMWR Morb. Mortal. Wkly. Rep. 46 (5): 107–9. PMID 9045037.
- ^ "Comvax package insert" (PDF). Retrieved 15 July 2018.
- ^ Zarei AE, Almehdar HA, Redwan EM (2016). "Hib Vaccines: Past, Present, and Future Perspectives". Journal of Immunology Research. 2016: 7203587. doi:10.1155/2016/7203587. PMC 4745871. PMID 26904695.
- v
- t
- e
Artificial induction of immunity / Immunization: Vaccines, Vaccination, Infection, Inoculation (J07)
- Adjuvants
- Vaccine ingredients
- Mathematical modelling
- Storage
- Timeline
- Trials
Bacterial |
|
---|---|
Viral |
|
Protozoan |
|
Helminthiasis |
|
Other |
researchers
- General
- MMR (Lancet MMR autism fraud)
- NCVIA
- Pox party
- Thiomersal
- Vaccines and SIDS
- Cedillo v. Secretary of Health and Human Services
- Alternative vaccination schedule
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e